Biological strategies expressed by different streptococcus pyogenes strains: An explanation of the epidemiology

Medical Hypotheses

Volumn 50, Issue 2, 1998, Pages 135-137

  Osterlund A ^a   Engstrand, L ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL VIRULENCE; ENDEMIC DISEASE; EPIDEMIC; HOST CELL; NONHUMAN; PRIORITY JOURNAL; SEROTYPING; STRAIN DIFFERENCE; STREPTOCOCCUS PYOGENES;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PYOGENES;

EID: 0031910251     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90199-2     Document Type: Article

References (17)

1. Katz A R, Morens D M. Severe streptococcal infections in historical perspective. Clin Infect Dis 1992; 14: 298-307.
2. Colman G, Tanna A, Efstratiou A, Gaworzewska E T. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 1993; 39: 165-178.
3. Schwartz B, Facklam R R, Breiman R F. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336: 1167-1171.
4. Martin P R, Höiby E A. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 1990; 22: 421-429.
5. Strömberg A, Romanus V, Burman L G. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 1991; 164: 595-598.
6. Chelsom J, Halstensen A, Haga T, Höiby E. Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994; 344: 1111-1115.
7. Talkington D F, Schwartz B, Black C M et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993; 61(8): 3369-3374
8. Carapetis J, Robins-Browne R, Martin D, Shelby-James T, Hogg G. Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypable clone. Clin Infect Dis 1995; 21: 1220-1227.
9. Andersen M M, Rønne T. Group A streptococcal bacteraemias in Denmark 1987-89. J Infect 1995; 31: 33-37.
10. Kristensen B, Schønheyder HC. A 13-year survey of bacteraemia due to β-haemolytic streptococci in a Danish county. J Med Microbiol 1995; 43: 63-67.
11. Österlund A. Epidemiological observations on Streptococcus pyogenes serotype T1 in Uppsala county, Sweden 1989-1995. APMIS 1996; 104: 168-170.
12. Cleary P P, Kaplan E L, Handley J P et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992; 339: 518-521 .
13. Musser JM, Kapur V, Kanjilal S et al. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). J Infect Dis 1993; 167(2): 337-346.
14. Norrby-Teglund A, Pauksens K, Holm S E, Norgren M. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J Infect Dis 1994; 170(3): 585-591.
15. Orrling A, Stjernquist-Desatnik A, Schalen C, Kamme C. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis 1994; 26(5): 535-541.
16. Zackrisson G, Lind L, Roos K, Larsson P. Eythromycinresistant beta-hemolytic streptococci group A in Göteborg, Sweden. Scand J Infect Dis 1988; 20: 419-420.
17. Miyamoto Y, Takizawa K, Matsushima A, Asai Y, Nakatsuka S. Stepwise acquisition of multiple drug resistance by betahemolytic streptococci and difference in resistance pattern by type. Antimicrob Agents Chemother 1978; 13: 399-404.